BROWN ADVISORY INC - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 20 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$416,837
-30.8%
74,836
+1.3%
0.00%0.0%
Q2 2023$602,608
+16.2%
73,8490.0%0.00%0.0%
Q1 2023$518,420
-15.9%
73,8490.0%0.00%0.0%
Q4 2022$616,639
+22.8%
73,8490.0%0.00%0.0%
Q3 2022$502,000
-18.9%
73,849
-4.5%
0.00%0.0%
Q2 2022$619,000
-28.7%
77,3490.0%0.00%0.0%
Q1 2022$868,000
-13.5%
77,349
+26.1%
0.00%0.0%
Q4 2021$1,004,000
-3.4%
61,350
-0.2%
0.00%
-50.0%
Q3 2021$1,039,00061,4500.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q2 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$4,686,8429.21%
VILLERE ST DENIS J & CO LLC 292,723$2,388,6190.17%
PINNACLE ASSOCIATES LTD 484,653$3,954,7680.07%
FNY Investment Advisers, LLC 1,539$120.02%
BENJAMIN F. EDWARDS & COMPANY, INC. 49,210$3990.02%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,171$187,9170.00%
BROWN ADVISORY INC 73,849$602,6080.00%
Geneos Wealth Management Inc. 750$6,0830.00%
Focused Wealth Management, Inc 242$1,9750.00%
UBS Group AG 6,548$53,4320.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders